HSF1 / Heat shock factor protein 1 · Western blot design guide

Design a Western Blot for HSF1

Real validated HSF1 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-HSF1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for HSF1: expected band ~57.3 kDa, hero antibody M00250-1, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable HSF1 Western blot protocol sheet — expected band ~57.3 kDa, antibody M00250-1, controls and PMC citations. Open the full HSF1 WB guide →

HSF1 Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~57.3 kDa
Observed band ~80 kDa
Gel 5–20% (catalog M00250-1)
Positive control ⓘ Adrenal gland (IHC candidate; verify WB) +4 more
Negative control ⓘ Suggested KO / knockdown lysate
Important caveats
Reasons your observed band may differ from the expected size.
PTM Phosphorylated + Acetylated
Caveat Modification-state controls
Gene-set association MSigDB C7 membership
Isoform 2 isoform(s)
Section 1

Real Curated HSF1 Western Blot Protocols

The M00250-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysatehuman Hela, human MCF-7, human K562 (catalog M00250-1)
Gel %5–20% (catalog M00250-1)
Load30 ug; reducing conditions (catalog M00250-1)
Transfera nitrocellulose membrane at 150 mA for 50-90 minutes (catalog M00250-1)
Membranenitrocellulose membrane (catalog M00250-1)
Blocking5% non-fat milk/TBS for 1.5 hour at RT (catalog M00250-1)
Primary antibodyM00250-1 · 1:500 (catalog M00250-1)
Primary incubationovernight at 4°C (catalog M00250-1)
Secondary antibodygoat anti-rabbit IgG-HRP, 1:5000 (catalog M00250-1)
Secondary incubation1.5 hour at RT (catalog M00250-1)
WashTBS-0.1%Tween 3 times with 5 minutes each (catalog M00250-1)
DetectionECL (catalog M00250-1)
Section 2

What Is the Expected HSF1 Western Blot Band Size?

HSF1 is predicted at 57.3 kDa, but an empirical band appears near 80 kDa; the cause of that difference is not established.

What am I looking at on my blot?
Band near 80 kDaEmpirical HSF1 band in reducing whole-cell lysates; identity warrants confirmation
Band near 57.3 kDaNear the sequence-predicted mass; identity remains unconfirmed
Several bands at different positionsLong and Short isoforms could contribute, but distinct migration is unverified
Weak nuclear-fraction band in unstressed cellsUnstressed HSF1 is described as a latent cytoplasmic monomer
💡Expected HSF1 appearanceHSF1 has a predicted mass of 57.3 kDa, while antibody QC shows a ~80 kDa band in reducing whole-cell lysates; the cause of the difference is unestablished, so confirm identity with knockdown or a second antibody.
How each factor affects band size
Predicted 57.3 kDa massSequence-based reference; the empirical band is ~80 kDa, with the difference unexplained
Long isoformMay have a different mass from Short; its migration is not supplied
Short isoformMay have a different mass from Long; its migration is not supplied
Long and Short splice isoformsCould yield more than one band, but a resolvable difference is unverified
Why is my band missing or off?
SituationLikely causeNext action
Band higher than expectedThe ~80 kDa empirical band exceeds the 57.3 kDa prediction for an unestablished reasonCheck an HSF1 knockdown and a second antibody
Band lower than expectedThe Short isoform is a possible contributor, but its migration is unknownConfirm identity with knockdown and isoform-aware controls
Multiple bandsLong and Short isoforms are possible contributors; other bands may be nonspecificCompare bands after HSF1 knockdown and with a second antibody
Weak or no signalUnstressed HSF1 is described as a latent cytoplasmic monomer, which may limit a nuclear-fraction signalCompare nuclear and cytoplasmic fractions and include a positive control
Fragments below expected sizeProtein breakdown during sample handling is possible; no HSF1 cleavage product is specifiedPrepare fresh samples with protease inhibitors and verify bands with a second epitope

Sample controls for HSF1 Western blot

🧪HPA-IHC candidate guidance (verify in WB): For positive controls for HSF1 in Western blot, you can use adrenal gland lysate, which has high HPA expression.
Positive control: Adrenal gland (IHC candidate; verify WB)
Negative control: Suggested KO / knockdown lysate
Loading controls: Run GAPDH, β-actin, and a total-protein stain alongside.
⚠️Feasibility: No clean negative tissue is listed; use siRNA knockdown or a KO line.

HPA tissue expression evidence for HSF1

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
Adrenal gland glandular cells High Protein (IHC) HPA →
Breast glandular cells High Protein (IHC) HPA →
Bronchus respiratory epithelial cells High Protein (IHC) HPA →
Cerebellum cells in molecular layer High Protein (IHC) HPA →
Cerebral cortex neuronal cells High Protein (IHC) HPA →

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
Appendix glandular cells Low Protein (IHC) HPA →
Liver cholangiocytes Low Protein (IHC) HPA →
Adipose tissue adipocytes Medium Protein (IHC) HPA →
Bone marrow hematopoietic cells Medium Protein (IHC) HPA →
Caudate glial cells Medium Protein (IHC) HPA →
Section 3

Advanced HSF1 Western Blot Tips

Deeper troubleshooting and optimisation questions for HSF1, answered from its protein features.

How should HSF1 band migration be interpreted?
Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.
How might the Long and Short isoforms affect band interpretation?
Isoforms · UniProt lists Long and Short isoforms. In Short, residues 462–489 are replaced and residues 490–529 are missing. Their bands may differ, but these sequence changes do not establish where either isoform will migrate. Check whether the antibody epitope is present in both isoforms before assigning bands.
Which HSF1 phosphorylation sites can guide a phospho-specific blot?
PTM · In UniProt numbering, MAPKAPK2 modifies Ser121, CK2 Thr142, PLK1 Ser216 and Ser419, GSK3-beta Ser303, MAPK3 Ser307, PKA Ser320, and MAPK12 Ser326. Match the antibody's stated site and numbering convention to the sequence. A phospho-specific signal measures that site, not necessarily total HSF1.

UniProt lists N6-acetyllysine at positions 80, 91, 118, 150, 188, 208, 298, and 524, with positions 91, 208, and 298 marked alternate. These are UniProt coordinates; check an antibody's numbering convention before comparing sites. Acetylation is a candidate for follow-up, but site annotation alone cannot identify an unexpected band or establish a visible shift.
Does this guide establish induction of HSF1?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
How should transfer be checked for HSF1?
Transfer · Standard workflow guidance: verify transfer efficiency for the intended target size before interpreting a weak signal. Use total-protein assessment and optimize transfer for the membrane, gel and apparatus; the labelled catalog values take precedence.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the M00250-1 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
How should HSF1 bands be quantified across samples?
Quantitation · Use the same band definition across samples and account for the Long and Short isoforms if the antibody detects both. UniProt lists cytoplasmic and nuclear localization, so compare like fractions. Report whether quantification represents one band, combined bands, total HSF1, or a site-specific phospho-HSF1 signal.
Why does HSF1 appear near 80 kDa instead of 57.3 kDa?
Interpretation · The canonical sequence predicts 57.3 kDa, while the supplied Western blot observation is approximately 80 kDa. UniProt lists extensive phosphorylation and acetylation, but those features alone do not establish the cause of the apparent mass difference. Use the observed band position as a reference and confirm identity with a suitable control.

UniProt identifies HSF1 with the stress response and describes a latent cytoplasmic monomer in unstressed cells; it also lists nuclear localization. Compare matched stressed and unstressed samples, and keep fractionation consistent if measuring nuclear HSF1. These features do not guarantee an increase in total protein or a visible band shift.

Check the antibody epitope against the Short isoform's replacement at 462–489 and deletion at 490–529. UniProt also lists many modified residues, but their presence does not prove that extra bands are modified HSF1. Compare the approximately 80 kDa reference band across matched samples and use a specificity control to test each assignment.
Boster reagents

HSF1 Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot analysis of HSF1 using anti-HSF1 antibody (M00250-1). Electrophoresis was performed on a 5-20% SDS-PAGE gel at 70V (Stacking gel) / 90V (Resolving gel) for 2-3 hours. The sample well of each lane was loaded with 30 ug of sample under reducing conditions. Lane 1: human Hela whole cell lysates, Lane 2: human MCF-7 whole cell lysates, Lane 3: human K562 whole cell lysates, Lane 4: human HepG2 whole cell lysates. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-HSF1 antigen affinity purified monoclonal antibody (Catalog # M00250-1) at 1:500 overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for HSF1 at approximately 80 kDa. The expected band size for HSF1 is at 57 kDa.
Anti-HSF1 Rabbit Monoclonal Antibody
Cat # M00250-1
Real WB data Western blot analysis of p-HSF1(S326) on different lysates using anti-p-HSF1(S326) antibody at 1/1,000 dilution. Positive control: Lane 1: Hela Lane 2: BT20 Lane 3: AGS
Anti-HSF1 (Phospho-S326) Antibody
Cat # A00250S326
Real WB data Western blot analysis of HSF1 using anti-HSF1 antibody (A00250). Electrophoresis was performed on a 5-20% SDS-PAGE gel at 70V (Stacking gel) / 90V (Resolving gel) for 2-3 hours. The sample well of each lane was loaded with 30 ug of sample under reducing conditions. Lane 1: human Hela whole cell lysates, Lane 2: human K562 whole cell lysates, Lane 3: human MCF-7 whole cell lysates, Lane 4: human MOLT-4 whole cell lysates, Lane 5: human 293T whole cell lysates. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-HSF1 antigen affinity purified polyclonal antibody (Catalog # A00250) at 0.25 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for HSF1 at approximately 80 kDa. The expected band size for HSF1 is at 57 kDa.
Anti-HSF1 Antibody Picoband®
Cat # A00250
Real WB data Western blot analysis of HSF1 using anti-HSF1 antibody (P00250). Electrophoresis was performed on a 5-20% SDS-PAGE gel at 70V (Stacking gel) / 90V (Resolving gel) for 2-3 hours. The sample well of each lane was loaded with 30 ug of sample under reducing conditions. Lane 1: human Hela whole cell lysates, Lane 2: human K562 whole cell lysates, Lane 3: human HepG2 whole cell lysates, Lane 4: human MCF-7 whole cell lysates. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-HSF1 antigen affinity purified monoclonal antibody (Catalog # P00250) at 1:500 overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:1000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for HSF1 at approximately 80 kDa. The expected band size for HSF1 is at 57 kDa.
Anti-Phospho-HSF1 (S326) Rabbit Monoclonal Antibody
Cat # P00250

All four antibodies list human reactivity and have WB images. The HSF1 captions report bands near 80 kDa despite a stated 57 kDa expected size. The images document specific cell lysates; they do not establish performance across all human samples.

Which to pick: For total HSF1, M00250-1 and A00250 show WB results in human cell lysates. For phospho-S326, A00250S326 shows HeLa, BT20, and AGS controls. P00250 is labeled phospho-S326, but its WB caption describes HSF1 without phosphorylation-specific evidence.

Source: BosterBio HSF1 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.